Factual end-of-day data for CONCORDBIO: price and volume, delivery percentage, 52-week position, indicator levels and intraday order flow. Refreshed after every NSE session.
Traded volume of 1,28,354 shares was close to the 20-day average.
CONCORDBIO's delivery share of 43.1% was in line with its 20-day average of 45.6%.
| Date | Close | Change | Volume | Delivered qty | Delivery % |
|---|---|---|---|---|---|
| 9 Oct 2026 | ₹1,361.40 | +2.30% | 1,28,354 | 55,359 | 43.1% |
| 8 Oct 2026 | ₹1,330.80 | -2.13% | 1,81,142 | 94,756 | 52.3% |
| 7 Oct 2026 | ₹1,359.70 | -0.66% | 43,657 | 22,281 | 51.0% |
| 6 Oct 2026 | ₹1,368.80 | +0.95% | 41,856 | 18,629 | 44.5% |
| 5 Oct 2026 | ₹1,355.90 | -1.32% | 55,394 | 20,798 | 37.5% |
| 1 Oct 2026 | ₹1,374.10 | +0.04% | 1,47,229 | 70,250 | 47.7% |
| 30 Sep 2026 | ₹1,373.60 | -2.63% | 1,00,957 | 49,439 | 49.0% |
| 29 Sep 2026 | ₹1,410.70 | +1.29% | 1,53,198 | 57,382 | 37.5% |
| 28 Sep 2026 | ₹1,392.70 | -4.19% | 1,09,961 | 59,277 | 53.9% |
| 25 Sep 2026 | ₹1,453.60 | -1.70% | 1,25,029 | 56,412 | 45.1% |
| 24 Sep 2026 | ₹1,478.80 | -5.22% | 3,17,814 | 1,39,543 | 43.9% |
| 23 Sep 2026 | ₹1,560.30 | +1.82% | 1,47,508 | 61,434 | 41.6% |
| 22 Sep 2026 | ₹1,532.40 | -2.98% | 1,70,913 | 75,937 | 44.4% |
| 21 Sep 2026 | ₹1,579.40 | +5.69% | 5,61,323 | 1,35,018 | 24.1% |
| 18 Sep 2026 | ₹1,494.40 | +2.28% | 1,70,417 | 58,015 | 34.0% |
| 17 Sep 2026 | ₹1,461.10 | +0.50% | 84,587 | 49,860 | 59.0% |
| 16 Sep 2026 | ₹1,453.80 | -1.30% | 1,05,795 | 45,477 | 43.0% |
| 15 Sep 2026 | ₹1,473.00 | -2.17% | 97,030 | 43,868 | 45.2% |
| 11 Sep 2026 | ₹1,505.70 | +3.64% | 3,72,504 | 1,58,997 | 45.0% |
| 10 Sep 2026 | ₹1,452.80 | -0.80% | 1,06,007 | 59,249 | 55.9% |
Compare with delivery percentage for all NSE stocks.
Intraday order-flow data from VolumeLens tick classification — the running difference between aggressive buying and selling volume.
Large-trade volume split: 0 shares on the buy side vs 782 on the sell side.
Largest single sell-side trade: 782 shares at ₹1,348.00.
| Indicator | Reading (9 Oct 2026) |
|---|---|
| RSI (14) | 41.5 |
| 50-day EMA | ₹1,418.42 — close is below |
| 200-day EMA | ₹1,360.86 — close is above |
| SuperTrend (10, 3) | ₹1,498.75 — close is below the line |
Indicator values are computed from adjusted daily closes and describe where price sits relative to each level — they are statistics, not signals.
CONCORDBIO is a mid-cap NSE stock in the Healthcare sector (Biotechnology industry), with a market capitalisation of about ₹14,333 crore.
Footprint chart, DOM ladder, cumulative delta and volume profile — free to explore.
On 9 Oct 2026, 43.1% of CONCORDBIO's traded volume was marked for delivery (55,359 shares delivered). The 20-day average delivery is 45.6%.
CONCORDBIO closed at ₹1,361.40 on 9 Oct 2026 (+2.30% vs the previous close).
52-week high ₹1,667.60, 52-week low ₹987.00. The latest close is -18.36% from the 52-week high.